These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 9455799

  • 1. Induction of expression of MHC-class-II antigen on human thyroid carcinoma by wild-type p53.
    Zeki K, Tanaka Y, Morimoto I, Nishimura Y, Kimura A, Yamashita U, Eto S.
    Int J Cancer; 1998 Jan 30; 75(3):391-5. PubMed ID: 9455799
    [Abstract] [Full Text] [Related]

  • 2. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells.
    Lu Y, Ussery GD, Muncaster MM, Gallie BL, Blanck G.
    Oncogene; 1994 Apr 30; 9(4):1015-9. PubMed ID: 8134104
    [Abstract] [Full Text] [Related]

  • 3. Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma.
    Becker JC, Brabletz T, Czerny C, Termeer C, Bröcker EB.
    Int Immunol; 1993 Dec 30; 5(12):1501-8. PubMed ID: 7906140
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I, Gulle H, Wolf HM, Maris M, Eggenbauer H, Eibl MM.
    J Exp Med; 1995 Apr 01; 181(4):1411-23. PubMed ID: 7699327
    [Abstract] [Full Text] [Related]

  • 10. Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53.
    Fagin JA, Tang SH, Zeki K, Di Lauro R, Fusco A, Gonsky R.
    Cancer Res; 1996 Feb 15; 56(4):765-71. PubMed ID: 8631011
    [Abstract] [Full Text] [Related]

  • 11. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
    Somasundaram R, Swoboda R, Caputo L, Lee A, Jackson N, Marincola FM, Guerry D, Herlyn D.
    Int J Cancer; 2003 Apr 10; 104(3):362-8. PubMed ID: 12569560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells.
    Shklyaev SS, Namba H, Sautin Y, Mitsutake N, Nagayama Y, Ishikawa N, Ito K, Zeki K, Yamashita S.
    Anticancer Res; 2001 Apr 10; 21(4A):2569-75. PubMed ID: 11724323
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo.
    Nagayama Y, Shigematsu K, Namba H, Zeki K, Yamashita S, Niwa M.
    Anticancer Res; 2000 Apr 10; 20(4):2723-8. PubMed ID: 10953350
    [Abstract] [Full Text] [Related]

  • 15. Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms.
    Fujita H, Senju S, Yokomizo H, Saya H, Ogawa M, Matsushita S, Nishimura Y.
    Eur J Immunol; 1998 Jan 10; 28(1):305-16. PubMed ID: 9485210
    [Abstract] [Full Text] [Related]

  • 16. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL, Suzuki K, Ohta M, Saito J, Ohmori M, Montani V, Napolitano G, Shong M, Taniguchi SI, Pietrarelli M, Lavaroni S, Mori A, Singer DS, Kohn LD.
    Endocrinology; 1998 May 10; 139(5):2300-13. PubMed ID: 9564838
    [Abstract] [Full Text] [Related]

  • 17. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
    Moretti F, Farsetti A, Soddu S, Misiti S, Crescenzi M, Filetti S, Andreoli M, Sacchi A, Pontecorvi A.
    Oncogene; 1997 Feb 13; 14(6):729-40. PubMed ID: 9038381
    [Abstract] [Full Text] [Related]

  • 18. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB, Cestari S.
    Cell Immunol; 1997 May 25; 178(1):79-90. PubMed ID: 9184701
    [Abstract] [Full Text] [Related]

  • 19. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
    Novellino L, Renkvist N, Rini F, Mazzocchi A, Rivoltini L, Greco A, Deho P, Squarcina P, Robbins PF, Parmiani G, Castelli C.
    J Immunol; 2003 Jun 15; 170(12):6363-70. PubMed ID: 12794170
    [Abstract] [Full Text] [Related]

  • 20. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER, Bang B, Larsen JK, Vejlsgaard GL, Baadsgaard O.
    Br J Dermatol; 1994 Dec 15; 131(6):780-8. PubMed ID: 7531998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.